Oncology Resource Group

Oncology Competitive Intelligence Leaders

Pre-ASH 2025 Analyst Briefing: Webinar

December 2, 2025

Patrick Nygren, Ph.D.

Access Briefing

    Watch Now






    Executive Summary: ONCrg analyst Patrick Nygren previews the highest-impact clinical presentations across hematologic malignancies at ASH 2025, covering CLL, multiple myeloma, NHL, and AML, with a focus on practice-changing phase 3 readouts and early-stage combination signals.

    • NHL
    • Multiple Myeloma
    • ASH 2025

      Sample Request

      How Did You Hear About Us

        Request Sample


        Please fill out the form below.

        We provide our samples for no charge to potential pharmaceutical clients, practicing physicians, and academic researchers.

        *Limited to one per year, other restrictions may apply.

        Select the Conferences of Interest:

          Request Planner


          Please fill out the form below.

          We provide our planners for no charge to potential pharmaceutical clients, practicing physicians, and academic researchers.

          *Limited to one per year, other restrictions may apply.

          Select the Conferences of Interest: